Loading organizations...
Lumio Capital operates as an investment firm specializing in purpose-driven capital deployment across specific, impactful sectors. The firm focuses on pioneering investments primarily within the healthcare and education industries, aiming to integrate world-class expertise with strategic financial backing. This approach allows Lumio Capital to foster growth and innovation in areas critical for societal advancement.
Dr. Mohamad Hamade is a principal figure associated with the establishment of Lumio Capital. The firm was founded on the insight that significant, positive change can be achieved through strategically targeted investments that align financial returns with broader social objectives. This vision guides their commitment to sectors where thoughtful investment can yield transformative outcomes.
The firm's clients are entities within the integrated healthcare delivery and next-generation innovation spaces. Lumio Capital's overarching mission is to build the future with integrity and clear intent, supporting ventures that promise both sustainable development and measurable societal benefit. They strive to be a catalyst for progress by enabling companies to scale and realize their potential.
Lumio Capital has 1 tracked investment across 1 company. The latest tracked deal is $26.0M Series A in Optain in September 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2025 | Optain | $26.0M Series A | Insight Partners | Afore Capital, Antiportfolio Ventures, Crossbeam Venture Partners, Overlooked Ventures, Right Side Capital Management, Stone Mountain Ventures, Evan Moore, Informed Ventures, Memorial Hermann Health System, Meridian Ventures, Northwell Health, Novant Health, The Ohio State University, Uniquest, UPMC |